339 related articles for article (PubMed ID: 23340380)
1. Influenza A virus entry inhibitors targeting the hemagglutinin.
Yang J; Li M; Shen X; Liu S
Viruses; 2013 Jan; 5(1):352-73. PubMed ID: 23340380
[TBL] [Abstract][Full Text] [Related]
2. The role of fusion activity of influenza A viruses in their biological properties.
Jakubcová L; Hollý J; Varečková E
Acta Virol; 2016 Jun; 60(2):121-35. PubMed ID: 27265461
[TBL] [Abstract][Full Text] [Related]
3. An Oleanolic Acid Derivative Inhibits Hemagglutinin-Mediated Entry of Influenza A Virus.
Ye M; Liao Y; Wu L; Qi W; Choudhry N; Liu Y; Chen W; Song G; Chen J
Viruses; 2020 Feb; 12(2):. PubMed ID: 32085430
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor.
Cao N; Cai Y; Huang X; Jiang H; Huang Z; Xing L; Lu L; Jiang S; Xu W
mBio; 2024 May; 15(5):e0074124. PubMed ID: 38587427
[TBL] [Abstract][Full Text] [Related]
5. Hemagglutinin Cleavability, Acid Stability, and Temperature Dependence Optimize Influenza B Virus for Replication in Human Airways.
Laporte M; Stevaert A; Raeymaekers V; Boogaerts T; Nehlmeier I; Chiu W; Benkheil M; Vanaudenaerde B; Pöhlmann S; Naesens L
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597759
[TBL] [Abstract][Full Text] [Related]
6. Role of host trypsin-type serine proteases and influenza virus-cytokine-trypsin cycle in influenza viral pathogenesis. Pathogenesis-based therapeutic options.
Kido H; Takahashi E; Kimoto T
Biochimie; 2019 Nov; 166():203-213. PubMed ID: 31518617
[TBL] [Abstract][Full Text] [Related]
7. Identification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput Screening.
Weisshaar M; Cox R; Morehouse Z; Kyasa SK; Yan D; Oberacker P; Mao S; Golden JE; Lowen AC; Natchus MG; Plemper RK
J Virol; 2016 Aug; 90(16):7368-7387. PubMed ID: 27252534
[TBL] [Abstract][Full Text] [Related]
8. Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines.
Jiang S; Li R; Du L; Liu S
Protein Cell; 2010 Apr; 1(4):342-354. PubMed ID: 21203946
[TBL] [Abstract][Full Text] [Related]
9. New small molecule entry inhibitors targeting hemagglutinin-mediated influenza a virus fusion.
Basu A; Antanasijevic A; Wang M; Li B; Mills DM; Ames JA; Nash PJ; Williams JD; Peet NP; Moir DT; Prichard MN; Keith KA; Barnard DL; Caffrey M; Rong L; Bowlin TL
J Virol; 2014 Feb; 88(3):1447-60. PubMed ID: 24198411
[TBL] [Abstract][Full Text] [Related]
10. Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry.
Wu W; Li R; Li X; He J; Jiang S; Liu S; Yang J
Viruses; 2015 Dec; 8(1):. PubMed ID: 26712783
[TBL] [Abstract][Full Text] [Related]
11. Competitive Cooperation of Hemagglutinin and Neuraminidase during Influenza A Virus Entry.
Du R; Cui Q; Rong L
Viruses; 2019 May; 11(5):. PubMed ID: 31137516
[TBL] [Abstract][Full Text] [Related]
12. Membrane Fusion and Infection of the Influenza Hemagglutinin.
Smrt ST; Lorieau JL
Adv Exp Med Biol; 2017; 966():37-54. PubMed ID: 27966108
[TBL] [Abstract][Full Text] [Related]
13. Hemagglutinin Stability and Its Impact on Influenza A Virus Infectivity, Pathogenicity, and Transmissibility in Avians, Mice, Swine, Seals, Ferrets, and Humans.
Russell CJ
Viruses; 2021 Apr; 13(5):. PubMed ID: 33923198
[TBL] [Abstract][Full Text] [Related]
14. TMPRSS2 Is the Major Activating Protease of Influenza A Virus in Primary Human Airway Cells and Influenza B Virus in Human Type II Pneumocytes.
Limburg H; Harbig A; Bestle D; Stein DA; Moulton HM; Jaeger J; Janga H; Hardes K; Koepke J; Schulte L; Koczulla AR; Schmeck B; Klenk HD; Böttcher-Friebertshäuser E
J Virol; 2019 Nov; 93(21):. PubMed ID: 31391268
[TBL] [Abstract][Full Text] [Related]
15. Infection of Mouse Macrophages by Seasonal Influenza Viruses Can Be Restricted at the Level of Virus Entry and at a Late Stage in the Virus Life Cycle.
Londrigan SL; Short KR; Ma J; Gillespie L; Rockman SP; Brooks AG; Reading PC
J Virol; 2015 Dec; 89(24):12319-29. PubMed ID: 26423941
[TBL] [Abstract][Full Text] [Related]
16. Acid-induced membrane fusion by the hemagglutinin protein and its role in influenza virus biology.
Russell CJ
Curr Top Microbiol Immunol; 2014; 385():93-116. PubMed ID: 25007844
[TBL] [Abstract][Full Text] [Related]
17. New influenza A Virus Entry Inhibitors Derived from the Viral Fusion Peptides.
Wu W; Lin D; Shen X; Li F; Fang Y; Li K; Xun T; Yang G; Yang J; Liu S; He J
PLoS One; 2015; 10(9):e0138426. PubMed ID: 26382764
[TBL] [Abstract][Full Text] [Related]
18. Chemoreactive-Inspired Discovery of Influenza A Virus Dual Inhibitor to Block Hemagglutinin-Mediated Adsorption and Membrane Fusion.
Wu G; Yu G; Yu Y; Yang S; Duan Z; Wang W; Liu Y; Yu R; Li J; Zhu T; Gu Q; Li D
J Med Chem; 2020 Jul; 63(13):6924-6940. PubMed ID: 32520560
[TBL] [Abstract][Full Text] [Related]
19. A Sialylated Voltage-Dependent Ca
Fujioka Y; Nishide S; Ose T; Suzuki T; Kato I; Fukuhara H; Fujioka M; Horiuchi K; Satoh AO; Nepal P; Kashiwagi S; Wang J; Horiguchi M; Sato Y; Paudel S; Nanbo A; Miyazaki T; Hasegawa H; Maenaka K; Ohba Y
Cell Host Microbe; 2018 Jun; 23(6):809-818.e5. PubMed ID: 29779930
[TBL] [Abstract][Full Text] [Related]
20. Entry of influenza A virus into host cells - recent progress and remaining challenges.
Sempere Borau M; Stertz S
Curr Opin Virol; 2021 Jun; 48():23-29. PubMed ID: 33838498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
